Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BETHESDa
2024-519269-23-00Phase 3Completed
- Sponsor
- Medical University of Warsaw
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of budesonide in Crohn's disease, sponsored by Medical University of Warsaw. Primary endpoint: Primary: Complete endoscopic and histopathological remission in upper gastrointestinal tract. Started Dec 2024; status: completed.
02
Drugs
budesonide
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2024-519269-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519269-23-00.